🔎 Trials Near Me

Home › Psoriatic Arthritis › Illinois

Pag-aaral pangklinika para sa Psoriatic Arthritis sa Illinois

6 pag-aaral para sa Psoriatic Arthritis ang naghahanap ng mga kalahok sa mga site sa Illinois.

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

  • Willow Rheumatology and Wellness PLLC, Willowbrook
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07321873

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  • GSCP/CIS, Orland Park
  • Greater Chicago Specialty Physicians LLC/CIS, Schaumburg
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06671483

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

  • Clinical Site, Springfield
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06641089

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

  • Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
  • University of Chicago Medical Center, Chicago
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

  • Pa0019 132, Chicago
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT07290036

Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis

  • Clinic Of Dr. Robert Hozman/Clinical Investigation Specialists, Inc /ID# 272879, Skokie
  • Willow Rheumatology and Wellness, PLLC /ID# 277354, Willowbrook
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT06865105

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.